Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Bridging science and creativity: a reflective session on liver health Birmingham researchers hosted a unique event that brought together liver disease patients, researchers, charity partners, and an artist in residence.
News Fontan circulation link to changes in genetic code may lead to new treatment for heart conditions
13 April 2024 Objective biomarker test could predict heart disease risk for patients with common arrhythmia Patients with Atrial Fibrillation deemed high risk following analysis had five times as many cardiovascular events as low-risk cluster
04 April 2024 Fontan circulation link to changes in genetic code may lead to new treatment for heart conditions Procedure used to treat children born with heart conditions may provide a new treatment opportunity
20 March 2024 Heart research receives BHF funding boost thanks to European partnership Team led by Dr Katja Gehmlich wins half a million pound grant to further understanding of condition called hypertrophic cardiomyopathy
29 February 2024 Improving screening in underrepresented groups for genetic condition with heart complications Birmingham researchers are working with community groups to help boost screening and diagnosis of a rare genetic condition in under-represented groups.
14 February 2024 First Patient treated in LIBERATE trial evaluating glenzocimab for heart attacks Partnership agreement with Acticor Biotech sees first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.
13 February 2024 Anabolic steroid use can increase heart disease risk Taking testosterone may increase the risk of atrial fibrillation in individuals with an existing predisposition
02 February 2024 Birmingham Platelet Group recognised in 2023 Pharmaceutical Technology Excellence Awards Birmingham researchers have been celebrated for their breakthrough work in thrombosis.